Skip to main content
Consultation outcome

Consultation Pack on applications for authorisation of 3 CBD food products as novel foods

Applies to England, Northern Ireland and Wales

This consultation has concluded

Detail of outcome

To view the final outcome and the FSA response to the consultation, please visit our website where the response will be published

Detail of feedback received

To view the feedback from the consultation, please visit our website where the response will be published


Original consultation

Summary

This consultation seeks stakeholders’ views, comments and feedback in relation to regulated product applications considered in this document. Launch date: 28 August 2025 Respond by: 20 November 2025

This consultation ran from
to

Consultation description

This consultation seeks stakeholders’ views, comments and feedback in relation to 3 regulated product applications. The applications are for authorisation of “synthetic cannabidiol (CBD)”, “cannabidiol (CBD) isolate” and “isolated cannabidiol (CBD) derived from hemp (Cannabis sativa)” as novel foods. The FSA will consider stakeholder responses before preparing final advice to ministers in England and Wales, with the Minister for Health in Northern Ireland kept informed. The determination on authorisation sits with ministers; the FSA has prepared draft recommendations for each application, which are included in the consultation. The draft recommendations are to authorise the 3 novel foods, subject to meeting the terms of authorisation that are set out in the consultation.

As these are the first applications for authorisation of CBD food products as novel foods to be subject to public consultation, the consultation also sets out a proposed approach to broader policy issues that will be relevant to future applications for CBD products, including enforcement issues and the protection of vulnerable groups. 

The overall aim of the Food Standards Agency (FSA) in developing these proposals has been to ensure a high level of consumer health protection, and to consider the wider consumer interest. Whilst the FSA is developing the policy and advice on these issues, ministers in England, Wales, and Scotland (advised by Food Standards Scotland (FSS)) are ultimately responsible for taking the decisions to authorise CBD food products as novel foods. This consultation and corresponding responses from stakeholders are intended to support the development of the FSA’s advice to ministers. The content of this consultation pack is not an indication of any UK minister’s views. Final advice to ministers in England, Scotland and Wales will be informed by the outcome of this consultation.   

Documents

Annexes - Consultation on applications for authorisation of 3 Cannabidiol (CBD) food products as novel foods August 2025

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email fsa.communications@food.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Updates to this page

Published 28 August 2025

Sign up for emails or print this page